Biotech Values

[genisi]

Could MNTA/Sandoz get approval w/o determining those molecular weights? If not, they are trying have it both ways, assuming they are able to

My thoughts were that by stating that mC would not be infringing because it "does not meet the asserted claims since it does not meet the molar ratio limitations (6:2:5:1) claimed in the patents", they actually say that mC is not identical to Teva's drug but still is "similar enough" in a manner that should satisfy the FDA. They must have some very strong methods of proving similarity.